Structural and degradative aspects of ornithine decarboxylase antizyme inhibitor 2

被引:11
|
作者
Ramos-Molina, Bruno [1 ,5 ]
Lambertos, Ana [1 ,5 ]
Lopez-Contreras, Andres J. [2 ]
Kasprzak, Joanna M. [3 ]
Czerwoniec, Anna [3 ]
Bujnicki, Janusz M. [4 ]
Cremades, Asuncion [1 ,5 ]
Penafiel, Rafael [1 ,5 ]
机构
[1] Univ Murcia, Fac Med, Dept Biochem & Mol Biol & Immunol B, E-30100 Murcia, Spain
[2] Spanish Natl Canc Res Ctr CNIO, Genom Instabil Grp, Madrid, Spain
[3] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Poznan, Poland
[4] Int Inst Mol & Cell Biol, Warsaw, Poland
[5] Inst Murciano Invest Biosanitaria, Murcia, Spain
来源
FEBS OPEN BIO | 2014年 / 4卷
关键词
Antizyme; Antizyme-binding element; Homology modeling; Polyamines; Protein degradation; Proteasome inhibitors; POLYAMINE METABOLISM; ANGSTROM RESOLUTION; HOMOLOGOUS PROTEIN; CELLS; EXPRESSION; GROWTH; PCONS; ACCUMULATION; RECOGNITION; FIBROBLASTS;
D O I
10.1016/j.fob.2014.05.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ornithine decarboxylase (ODC) is the key enzyme in the polyamine biosynthetic pathway. ODC levels are controlled by polyamines through the induction of antizymes (AZs), small proteins that inhibit ODC and target it to proteasomal degradation without ubiquitination. Antizyme inhibitors (AZIN1 and AZIN2) are proteins homologous to ODC that bind to AZs and counteract their negative effect on ODC. Whereas ODC and AZIN1 are well-characterized proteins, little is known on the structure and stability of AZIN2, the lastly discovered member of this regulatory circuit. In this work we first analyzed structural aspects of AZIN2 by combining biochemical and computational approaches. We demonstrated that AZIN2, in contrast to ODC, does not form homodimers, although the predicted tertiary structure of the AZIN2 monomer was similar to that of ODC. Furthermore, we identified conserved residues in the antizyme-binding element, whose substitution drastically affected the capacity of AZIN2 to bind AZ1. On the other hand, we also found that AZIN2 is much more labile than ODC, but it is highly stabilized by its binding to AZs. Interestingly, the administration of the proteasome inhibitor MG132 caused differential effects on the three AZ-binding proteins, having no effect on ODC, preventing the degradation of AZIN1, but unexpectedly increasing the degradation of AZIN2. Inhibitors of the lysosomal function partially prevented the effect of MG132 on AZIN2. These results suggest that the degradation of AZIN2 could be also mediated by an alternative route to that of proteasome. These findings provide new relevant information on this unique regulatory mechanism of polyamine metabolism. (C) 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This is an open access article under the CC BY-NC-ND license.
引用
收藏
页码:510 / 521
页数:12
相关论文
共 50 条
  • [1] Ornithine decarboxylase antizyme inhibitor 2 regulates intracellular vesicle trafficking
    Kanerva, Kristiina
    Makitie, Laura T.
    Back, Nils
    Andersson, Leif C.
    EXPERIMENTAL CELL RESEARCH, 2010, 316 (11) : 1896 - 1906
  • [2] Critical Factors Governing the Difference in Antizyme-Binding Affinities between Human Ornithine Decarboxylase and Antizyme Inhibitor
    Liu, Yen-Chin
    Liu, Yi-Liang
    Su, Jia-Yang
    Liu, Guang-Yaw
    Hung, Hui-Chih
    PLOS ONE, 2011, 6 (04):
  • [3] Role of ornithine decarboxylase antizyme inhibitor in vivo
    Tang, Hua
    Ariki, Kimi
    Ohkido, Makiko
    Murakami, Yasuko
    Matsufuji, Senya
    Li, Zhenghua
    Yamamura, Ken-ichi
    GENES TO CELLS, 2009, 14 (01) : 79 - 87
  • [4] Minimal Antizyme Peptide Fully Functioning in the Binding and Inhibition of Ornithine Decarboxylase and Antizyme Inhibitor
    Hsieh, Ju-Yi
    Yang, Jung-Yen
    Lin, Chih-Li
    Liu, Guang-Yaw
    Hung, Hui-Chih
    PLOS ONE, 2011, 6 (09):
  • [5] Mutational analysis of the antizyme-binding element reveals critical residues for the function of ornithine decarboxylase
    Ramos-Molina, Bruno
    Lambertos, Ana
    Lopez-Contreras, Andres J.
    Penafiel, Rafael
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2013, 1830 (11): : 5157 - 5165
  • [6] Docking of Antizyme to Ornithine Decarboxylase and Antizyme Inhibitor using Experimental Mutant and Double-Mutant Cycle Data
    Cohavi, Ori
    Tobi, Dror
    Schreiber, Gideon
    JOURNAL OF MOLECULAR BIOLOGY, 2009, 390 (03) : 503 - 515
  • [7] Filarial parasites possess an antizyme but lack a functional ornithine decarboxylase
    Kurosinski, Marc-Andre
    Lueersen, Kai
    Ndjonka, Dieudonne
    Younis, Abuelhassan Elshazly
    Brattig, Norbert W.
    Liebau, Eva
    ACTA TROPICA, 2013, 126 (03) : 167 - 176
  • [8] The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification
    Geerts, Dirk
    Koster, Jan
    Albert, David
    Koomoa, Dana-Lynn T.
    Feith, David J.
    Pegg, Anthony E.
    Volckmann, Richard
    Caron, Huib
    Versteeg, Rogier
    Bachmann, Andre S.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (09) : 2012 - 2024
  • [9] High expression of antizyme inhibitor 2, an activator of ornithine decarboxylase in steroidogenic cells of human gonads
    Makitie, Laura T.
    Kanerva, Kristiina
    Sankila, Anna
    Andersson, Leif C.
    HISTOCHEMISTRY AND CELL BIOLOGY, 2009, 132 (06) : 633 - 638
  • [10] Multifaceted interactions and regulation between antizyme and its interacting proteins cyclin D1, ornithine decarboxylase and antizyme inhibitor
    Liu, Yen-Chin
    Lee, Chien-Yun
    Lin, Chi-Li
    Chen, Hui-Yi
    Liu, Guang-Yaw
    Hung, Hui-Chih
    ONCOTARGET, 2015, 6 (27) : 23917 - 23929